EMEA (Europe, Middle East and Africa) Primary Biliary Cirrhosis Drug Market Report 2018

January 2018 | 100 pages | ID: E4D1135D8C7EN
QYResearch

Abstracts

In this report, the EMEA Primary Biliary Cirrhosis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Primary Biliary Cirrhosis Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Primary Biliary Cirrhosis Drug market competition by top manufacturers/players, with Primary Biliary Cirrhosis Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AlbireoPharma
• CymaBay Therapeutics, Inc.
• Dr. Falk Pharma GmbH
• Enanta Pharmaceuticals, Inc.
• GlaxoSmithKline Plc
• Intercept Pharmaceuticals, Inc.
• Johnson & Johnson
• MediGene AG
• NGM Biopharmaceuticals, Inc.
• Virobay Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Budesonide
• FFP-104
• GSK-2330672
• MBX-8025
• NGM-282
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Primary Biliary Cirrhosis Drug Market Report 2017

1 PRIMARY BILIARY CIRRHOSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Primary Biliary Cirrhosis Drug
1.2 Classification of Primary Biliary Cirrhosis Drug
  1.2.1 EMEA Primary Biliary Cirrhosis Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Primary Biliary Cirrhosis Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Budesonide
  1.2.4 FFP-104
  1.2.5 GSK-2330672
  1.2.6 MBX-8025
  1.2.7 NGM-282
  1.2.8 Others
1.3 EMEA Primary Biliary Cirrhosis Drug Market by Application/End Users
  1.3.1 EMEA Primary Biliary Cirrhosis Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Primary Biliary Cirrhosis Drug Market by Region
  1.4.1 EMEA Primary Biliary Cirrhosis Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Primary Biliary Cirrhosis Drug (2012-2022)
  1.5.1 EMEA Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2022)

2 EMEA PRIMARY BILIARY CIRRHOSIS DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Primary Biliary Cirrhosis Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Primary Biliary Cirrhosis Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Primary Biliary Cirrhosis Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Primary Biliary Cirrhosis Drug Sale Price by Players (2012-2017)
2.2 EMEA Primary Biliary Cirrhosis Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Primary Biliary Cirrhosis Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Primary Biliary Cirrhosis Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Primary Biliary Cirrhosis Drug Sale Price by Type (2012-2017)
2.3 EMEA Primary Biliary Cirrhosis Drug (Volume) by Application
2.4 EMEA Primary Biliary Cirrhosis Drug (Volume and Value) by Region
  2.4.1 EMEA Primary Biliary Cirrhosis Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Primary Biliary Cirrhosis Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Primary Biliary Cirrhosis Drug Sales Price by Region (2012-2017)

3 EUROPE PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
  3.1.1 Europe Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Primary Biliary Cirrhosis Drug Sales and Market Share by Type
3.3 Europe Primary Biliary Cirrhosis Drug Sales and Market Share by Application
3.4 Europe Primary Biliary Cirrhosis Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Primary Biliary Cirrhosis Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Primary Biliary Cirrhosis Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
  4.1.1 Middle East Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Primary Biliary Cirrhosis Drug Sales and Market Share by Type
4.3 Middle East Primary Biliary Cirrhosis Drug Sales and Market Share by Application
4.4 Middle East Primary Biliary Cirrhosis Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Primary Biliary Cirrhosis Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Primary Biliary Cirrhosis Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)

5 AFRICA PRIMARY BILIARY CIRRHOSIS DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
  5.1.1 Africa Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Primary Biliary Cirrhosis Drug Sales and Market Share by Type
5.3 Africa Primary Biliary Cirrhosis Drug Sales and Market Share by Application
5.4 Africa Primary Biliary Cirrhosis Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Primary Biliary Cirrhosis Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Primary Biliary Cirrhosis Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)

6 EMEA PRIMARY BILIARY CIRRHOSIS DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AlbireoPharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CymaBay Therapeutics, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dr. Falk Pharma GmbH
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Enanta Pharmaceuticals, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Intercept Pharmaceuticals, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MediGene AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 NGM Biopharmaceuticals, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Virobay Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Primary Biliary Cirrhosis Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 PRIMARY BILIARY CIRRHOSIS DRUG MANUFACTURING COST ANALYSIS

7.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PRIMARY BILIARY CIRRHOSIS DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Primary Biliary Cirrhosis Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Primary Biliary Cirrhosis Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Primary Biliary Cirrhosis Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Primary Biliary Cirrhosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Primary Biliary Cirrhosis Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Primary Biliary Cirrhosis Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Primary Biliary Cirrhosis Drug
Figure EMEA Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Budesonide Product Picture
Figure FFP-104 Product Picture
Figure GSK-2330672 Product Picture
Figure MBX-8025 Product Picture
Figure NGM-282 Product Picture
Figure Others Product Picture
Figure EMEA Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Primary Biliary Cirrhosis Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Primary Biliary Cirrhosis Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales Share by Players (2012-2017)
Figure 2016 Primary Biliary Cirrhosis Drug Sales Share by Players
Figure 2017 Primary Biliary Cirrhosis Drug Sales Share by Players
Figure EMEA Primary Biliary Cirrhosis Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Primary Biliary Cirrhosis Drug Revenue Share by Players
Table 2017 EMEA Primary Biliary Cirrhosis Drug Revenue Share by Players
Table EMEA Primary Biliary Cirrhosis Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2012-2017)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share by Type (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Type in 2016
Table EMEA Primary Biliary Cirrhosis Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Application (2012-2017)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share by Application in 2016
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Region (2012-2017)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share in 2016
Table EMEA Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Primary Biliary Cirrhosis Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Region (2012-2017)
Figure EMEA Primary Biliary Cirrhosis Drug Revenue Market Share Regions in 2016
Table EMEA Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Market Share by Type (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Market Share by Type in 2016
Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Market Share by Application (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Market Share by Application in 2016
Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales Market Share by Countries (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Market Share by Countries (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Market Share by Countries in 2016
Table Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Revenue Market Share by Countries in 2016
Figure Germany Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Market Share by Type (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Market Share by Type (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Market Share by Applications (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Sales Market Share by Application in 2016
Table Middle East Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Sales Volume Market Share by Countries in 2016
Table Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Primary Biliary Cirrhosis Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Sales Market Share by Type (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share by Type (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share by Type in 2016
Table Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Sales Market Share by Application (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share by Application (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Sales Market Share by Countries (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share by Countries (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share by Countries in 2016
Table Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Primary Biliary Cirrhosis Drug Revenue Market Share by Countries in 2016
Figure South Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information List
Table AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information List
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information List
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Basic Information List
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table MediGene AG Primary Biliary Cirrhosis Drug Basic Information List
Table MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Market Share in EMEA (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Biliary Cirrhosis Drug
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Primary Biliary Cirrhosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
Table Major Buyers of Primary Biliary Cirrhosis Drug
Table Distributors/Traders List
Figure EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources